Review on clinical trials of targeted treatments in malignant mesothelioma

Jan Nyrop Jakobsen; Jens Benn Sørensen

doi:10.1007/s00280-011-1655-3

Review on clinical trials of targeted treatments in malignant mesothelioma

Jan Nyrop Jakobsen, Jens Benn Sørensen

40 Citationer (Scopus)

Abstract

Malignant mesothelioma (MM) is an aggressive tumor of the serosal surfaces with a poor prognosis. Advances in the understanding of tumor biology have led to the development of several targeted treatments, which have been evaluated in clinical trials. This article is a comprehensive review of all clinical trials evaluating the effect of targeted treatments in MM.

Originalsprog	Engelsk
Tidsskrift	Cancer Chemotherapy and Pharmacology
Vol/bind	68
Udgave nummer	1
Sider (fra-til)	1-15
Antal sider	15
ISSN	0344-5704
DOI	https://doi.org/10.1007/s00280-011-1655-3
Status	Udgivet - jul. 2011

Adgang til dokumentet

10.1007/s00280-011-1655-3

Citationsformater

@article{9e60524ddd4e43af91dd250f57c81a6d,

title = "Review on clinical trials of targeted treatments in malignant mesothelioma",

abstract = "Malignant mesothelioma (MM) is an aggressive tumor of the serosal surfaces with a poor prognosis. Advances in the understanding of tumor biology have led to the development of several targeted treatments, which have been evaluated in clinical trials. This article is a comprehensive review of all clinical trials evaluating the effect of targeted treatments in MM.",

keywords = "Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Clinical Trials as Topic, Humans, Mesothelioma, Molecular Targeted Therapy, Pleural Neoplasms",

author = "Jakobsen, {Jan Nyrop} and S{\o}rensen, {Jens Benn}",

year = "2011",

month = jul,

doi = "10.1007/s00280-011-1655-3",

language = "English",

volume = "68",

pages = "1--15",

journal = "Cancer Chemotherapy and Pharmacology",

issn = "0344-5704",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "1",

}

TY - JOUR

T1 - Review on clinical trials of targeted treatments in malignant mesothelioma

AU - Jakobsen, Jan Nyrop

AU - Sørensen, Jens Benn

PY - 2011/7

Y1 - 2011/7

N2 - Malignant mesothelioma (MM) is an aggressive tumor of the serosal surfaces with a poor prognosis. Advances in the understanding of tumor biology have led to the development of several targeted treatments, which have been evaluated in clinical trials. This article is a comprehensive review of all clinical trials evaluating the effect of targeted treatments in MM.

AB - Malignant mesothelioma (MM) is an aggressive tumor of the serosal surfaces with a poor prognosis. Advances in the understanding of tumor biology have led to the development of several targeted treatments, which have been evaluated in clinical trials. This article is a comprehensive review of all clinical trials evaluating the effect of targeted treatments in MM.

KW - Antineoplastic Agents

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Clinical Trials as Topic

KW - Humans

KW - Mesothelioma

KW - Molecular Targeted Therapy

KW - Pleural Neoplasms

U2 - 10.1007/s00280-011-1655-3

DO - 10.1007/s00280-011-1655-3

M3 - Journal article

C2 - 21553148

SN - 0344-5704

VL - 68

SP - 1

EP - 15

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

IS - 1

ER -

Review on clinical trials of targeted treatments in malignant mesothelioma

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater